Summit Securities Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
Summit Securities Group's CNMD Position: Q3 2026 in Review
Summit Securities Group opened a new position in CONMED (CNMD) in Q3 2026: 500 shares worth $23.1K. The stake represents ﹤0.01% of the portfolio and ranks #686 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in CNMD as recently as Q3 2014.
Summit Securities Group first reported a position in CNMD in Q3 2014 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.
- Summit Securities Group held 500 shares of CONMED worth $23.1K as of Q3 2026.
- CONMED was a new Summit Securities Group position in Q3 2026.
- CONMED made up ﹤0.01% of Summit Securities Group's portfolio in Q3 2026, its #686 holding.
- Summit Securities Group first reported a position in CONMED in Q3 2014 and has held it in 2 quarters since.
- 117 funds tracked by Wall St. Rank held CONMED as of Q3 2026.
Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.